Skip to main content
. 2022 Oct 14;12:989713. doi: 10.3389/fonc.2022.989713

Table 1.

Patients’ characteristics.

Characteristics Patients (n)753 (%)100
Gender:
Men 435 (57.8)
Women 318 (42.2)
Age at referral (years):
Median (IQR) 68 (60–76)
< 70 years 401 (53.3)
≥ 70 years 352 (46.7)
Tumor site:
Gastrointestinal (GI) 566 (75.2)
Genitourinary (GU) 113 (15.0)
Other (sarcoma, lymphoma, gynecological) 74 (9.8)
Karnofsky Performance Status:
≥70 661 (87.8)
50-60 92 (12.2)
Tumor stage:
Locally advanced 47 (6.2)
Metastatic 684 (90.9)
Missing 22 (2.9)
Treatment line:
First line 338 (44.9)
Second line 192 (25.5)
Third or further lines 223 (29.6)
Years since cancer diagnosis:
≤1 351 (51.8)
>1 326 (48.2)
Survival from the SCOC visit (months):
Median (95% CI) 7.3 (6.5-8.0)